drugset / Trial / NCT03282825
Clinical Study of Decitabine and Paclitaxel Combination Therapy
NaSingle-groupOpen-labelTreatment
Summary
Phase Ib clinical study of Decitabine and Paclitaxel combination therapy
Timeline
- Start
- 2017-03-28
- Primary completion
- 2018-02
- Completion
- 2018-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Decitabine | Small molecule | 15 mg/m2 | Intravenous |
| Subject | Decitabine | Small molecule | 20 mg/m2 | Intravenous |
| Subject | Decitabine | Small molecule | 25 mg/m2 | Intravenous |
| Background | Paclitaxel | Small molecule | 80 mg/m2 | Intravenous |